EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Track record

Tools

  • Compare
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›HTFL

HTFL

Heartflow, Inc.

Next earnings Sep 17, 2026 · consensus $-0.14 EPS, $57.9M rev

Last earnings +3.3% on 2026-05-14

Hold
$35.65
▲ +1.92%
$35.65▲ +87.63%
over 1Y
L $19.00EODHDH $39.91
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+1.9%
1W+5.3%
1M+21.8%
3M+44.4%
YTD+23.1%
1Y+87.6%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
D
Valuation
Fair value
Filings
Clean
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 13 analysts
Buy

Revenue grew 39.9% YoY; but unprofitable (net margin -66.3%).

Heartflow, Inc. shows $176M in FY2025 revenue (+39.9% YoY), a -66.3% net margin, and -38.8% ROE.

Financials · annual, by fiscal year

Line itemFY23FY24FY25
Revenue$87.2M$126M$176M
Gross profit$58.1M$94.4M$135M
Operating income-$72.9M-$61.2M-$64.1M
Net income-$95.7M-$96.4M-$117M
Diluted EPS-$25.32-$17.98-$3.17
Net margin-109.7%-76.6%-66.3%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$3.01B
EV / EBITDA—
EV / Sales17.1
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-3.8%
FCF yield-1.9%

Quality & risk

ROIC (est.)-16.8%
Free cash flow-$59.0M
Total debt—
Net cash$44.8M
Altman Z-Score27.45 safe
Piotroski F-Score4/7

Capital returns

Buyback yield0.0%
Dividend yield (est.)—
Shareholder yield0.0%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Routine disclosure cadence — no material red flags in recent filings.
  1. 8-K Shareholder vote2026-06-18
  2. 8-K Earnings results2026-05-14
  3. 10-Q Quarterly report2026-05-14
  4. DEF 14A Proxy statement2026-04-29
  5. 8-K Earnings results2026-03-18
  6. 10-K Annual report2026-03-18
  7. 8-K Reg FD disclosure2026-01-12
  8. 8-K Earnings results2025-11-12
  9. 10-Q Quarterly report2025-11-12

Recent filings

all on EDGAR ↗
4Period ending 2026-06-242026-06-26open ↗144Filing2026-06-24open ↗4Period ending 2026-06-162026-06-18open ↗4Period ending 2026-06-162026-06-18open ↗4Period ending 2026-06-162026-06-18open ↗4Period ending 2026-06-162026-06-18open ↗4Period ending 2026-06-162026-06-18open ↗4Period ending 2026-06-162026-06-18open ↗8-KPeriod ending 2026-06-162026-06-18open ↗4Period ending 2026-06-152026-06-17open ↗4Period ending 2026-06-102026-06-12open ↗144Filing2026-06-10open ↗

Quality score

D
ValueGrowthProfitHealthMom.
ValueF
GrowthC
ProfitabilityF
Financial healthB-
Momentum—
  • ✓Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
Revenue
$176M
+39.9% YoY
Net margin
-66.3%
ROE
-38.8%
P/E
—

SEC fundamentals · FY 2025

'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$176M+39.9%
Net income-$117M-21.1%
Gross profit$135M+43.1%
Operating income-$64.1M-4.6%
Diluted EPS-$3.17+82.4%
Cash & equivalents$44.8M-12.8%
Total assets$359M+202.8%
Total liabilities$58.8M-71.9%
Stockholders' equity$301M+135.0%
Gross: 76.8%Op.: -36.4%L/E: 0.20x

Frequently asked

Is Heartflow, Inc. (HTFL) a buy?
HTFL currently carries a Hold rating with 2/5 conviction, derived from its latest SEC filings. Revenue grew 39.9% YoY; but unprofitable (net margin -66.3%).
What is Heartflow, Inc.'s quality score?
HTFL scores 40.058823529411754/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001464521, latest 10-Q filed 2026-05-14) · EODHD · as of 6/26/2026, 6:15:13 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 0 open-market buys · 1 sale

2026-06-24
Farquhar John C.M.
Chief Executive Officer
Sell38.9K @ $35.00$1.36M
2026-06-15
Rogers Campbell
Chief Medical Officer
Exercise10.0K @ $2.22$22.2K

Earnings history

beat/miss · move
2026-05-14Miss -20.1% est▲ +3.33%8-K ↗
2026-03-18Beat +30.3% est▲ +13.10%8-K ↗
2025-11-12Miss -56.0% est▲ +4.59%8-K ↗
2025-09-10Miss -534.6% est▼ -3.52%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
HeartFlow vs. NovoCure: Which Emerging Healthcare Stock Is a Better Buy in 2026?Bullish
finance.yahoo.com· 2026-06-24
Is HeartFlow Stock a Buy After an Institutional Investor Initiated a Position Worth $2.7 Million?Bullish
nasdaq.com· 2026-05-31
HeartFlow forecasts $228M-$232M 2026 revenue as Plaque outlook rises to $19M-$21MBullish
seekingalpha.com· 2026-05-15
Wall Street Waits for the SpaceX IPO, These 2 Under-the-Radar IPOs Could Already Be Making You MoneyBullish
finance.yahoo.com· 2026-05-12
The Future of Intoxication Detection May Be in Your VoiceBullish
globenewswire.com· 2026-05-11
Should You Consider Adding Heartflow (HTFL) to Your Portfolio?Bullish
finance.yahoo.com· 2026-05-08

Vs tracked universe

compare →

1044 tracked peers · median

EDGAR Score40 vs 67
Revenue growth39.9% vs 7.1%
Net margin-66.3% vs 10.5%
Return on equity-38.8% vs 12.3%
P/E— vs 25.5

News sentiment

EODHD · 6d
Bullish
+0.17
vs typical · 6 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.